VVOS icon

Vivos Therapeutics
VVOS

Overview Fund Trends Analyst Outlook Journalist POV

10 hedge funds and large institutions have $3.88M invested in Vivos Therapeutics in 2020 Q4 according to their latest regulatory filings, with 10 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
10
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.77M
2
+$540K
3
+$493K
4
KPF
K2 Principal Fund
Ontario, Canada
+$304K
5
MA
MYDA Advisors
New York
+$260K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.77M
2
$540K
3
$493K
4
$304K
5
$260K
6
$197K
7
$191K
8
$118K
9
$6K
10
$440